← Browse by Condition
Medical Condition

elective cardiac surgery

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for elective cardiac surgery sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — elective cardiac surgery Clinical Trials

How many clinical trials are currently recruiting for elective cardiac surgery?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for elective cardiac surgery, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for elective cardiac surgery?
elective cardiac surgery research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a elective cardiac surgery clinical trial?
Eligibility criteria for elective cardiac surgery trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Instituto Mexicano del Seguro Social 1 trial
GCP-Service International West GmbH 1 trial

Recruiting Clinical Trials

NCT06516432
Recruiting
Parasternal Blockade and Serum Lactate in Cardiac Surgery
Enrollment
86 pts
Location
Mexico
Sponsor
Instituto Mexicano del Seguro ...
View Trial →
NCT06279793 Phase 2
Recruiting
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
Enrollment
550 pts
Location
Germany
Sponsor
GCP-Service International West...
View Trial →

Related Conditions

intensive care unit (1) coronary artery bypass grafting cabg (1) high risk patients (1) cardiopulmonary bypass (1) valvular heart surgery (1) multiple valve surgeries (1) combined cardiac procedures (1) aortic surgical procedures (1) adult patients 18 years (1) combined valve and cabg (1) combined cardiac and aortic surgical procedures (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology